Virtu KCG Holdings’s Acer Therapeutics Inc ACER Stock Holding History

Virtu KCG Holdings’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$11K	Sell	1,687 -4,098	-71%	-$27.2K	﹤0.01%	2773
2017 Q1	$48K	Buy	5,785 +4,274	+283%	+$42K	﹤0.01%	2851
2016 Q4	$14K	Sell	1,511 -697	-32%	-$12.2K	﹤0.01%	3267
2016 Q3	$73K	Buy	+2,208	New	+$92.7K	﹤0.01%	2719
2016 Q1	–	Sell	-1,305	Closed	-$38K	–	3840
2015 Q4	$38K	Buy	+1,305	New	+$43.2K	﹤0.01%	3204
2015 Q2	–	Sell	-761	Closed	-$35K	–	3870
2015 Q1	$35K	Sell	761 -85	-10%	-$5.22K	﹤0.01%	2884
2014 Q4	$51K	Buy	846 +203	+32%	+$14.7K	﹤0.01%	3429
2014 Q3	$53K	Buy	+643	New	+$76.3K	﹤0.01%	3332
2014 Q2	–	Sell	-164	Closed	-$25K	–	4156
2014 Q1	$25K	Sell	164 -657	-80%	-$99.7K	﹤0.01%	3409
2013 Q4	$124K	Buy	821 +69	+9%	+$11.2K	﹤0.01%	3372
2013 Q3	$137K	Buy	+752	New	+$101K	﹤0.01%	3280

Other funds holding ACER

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu KCG Holdings's ACER Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Acer Therapeutics Inc (ACER) stake by 71% in Q2 2017, selling an estimated $27.2K and leaving 1,687 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2773.

Virtu KCG Holdings first reported a position in ACER in Q3 2013 and has held it in 11 quarters since. The position peaked at $137K in Q3 2013. 13 funds tracked by Wall St. Rank hold ACER as of Q2 2017.

Virtu KCG Holdings held 1,687 shares of Acer Therapeutics Inc worth $11K as of Q2 2017.
Virtu KCG Holdings sold 4,098 Acer Therapeutics Inc shares in Q2 2017, an estimated $27.2K.
Acer Therapeutics Inc made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2773 holding.
Virtu KCG Holdings first reported a position in Acer Therapeutics Inc in Q3 2013 and has held it in 11 quarters since.
Virtu KCG Holdings's Acer Therapeutics Inc position peaked at $137K in Q3 2013.
13 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.